Gene · 2273
Papers1,852
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,852
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-associated fibroblast-derived fibulin-5 promotes epithelial-mesenchymal transition in diffuse-type gastric cancer via cAMP response element-binding protein pathway, showing poor prognosis. | Exp Mol Med | 2025 | 40369121 | PubTator, text mining | PubMed |
| A chemical-genetic system to rapidly inhibit the PP2A-B56 phosphatase reveals a role at metaphase kinetochores. | Nat Commun | 2025 | 40157924 | PubTator, text mining | PubMed |
| Autoantibodies Against Factor B and Factor H Without Pathogenic Effects in a Patient with Immune Complex-Mediated Membranoproliferative Glomerulonephritis. | Biomedicines | 2025 | 40149624 | PubTator, text mining | PubMed |
| Common Haplotypes within the Chromosome 1q31.3 Region Determine Systemic Concentrations of the Entire Complement Factor H Protein Family. | J Innate Immun | 2025 | 40139172 | PubTator, text mining | PubMed |
| Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study. | J Transl Med | 2025 | 40075380 | PubTator, text mining | PubMed |
| RNA Sequencing Confirms the Pathogenicity of a Novel FHL1 Deletion in a Kinship With Emery-Dreifuss Muscular Dystrophy. | J Clin Neuromuscul Dis | 2025 | 40009419 | PubTator, text mining | PubMed |
| Metagenomic and Transcriptomic Analysis Reveals Crosstalk Between Intratumor Mycobiome and Hosts in Early-Stage Nonsmoking Lung Adenocarcinoma Patients. | Thorac Cancer | 2025 | 39853685 | PubTator, text mining | PubMed |
| FHL1 as a prognostic biomarker and therapeutic target in acute promyelocytic leukaemia. | Discov Oncol | 2025 | 39827436 | PubTator, text mining | PubMed |
| FHL1 Inhibition by miR-1301-3p Promotes Uterine Corpus Endometrial Carcinoma Cell Proliferation and Migration: A Prognostic Insight. | Curr Med Chem | 2025 | 39665305 | PubTator, text mining | PubMed |
| MiR-223-3p Promotes Osteoporosis Progression by Repressing Osteogenic Differentiation via Targeting FHL1/Wnt/β-catenin Signaling. | Cell Biochem Biophys | 2025 | 39613991 | PubTator, text mining | PubMed |
| Role of four and a half LIM domain protein 1 in tumors (Review). | Oncol Lett | 2025 | 39512507 | PubTator, text mining | PubMed |
| Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis. | Rheumatology (Oxford) | 2025 | 38833674 | PubTator, text mining | PubMed |
| The FHL1 myopathy spectrum revisited: a literature review and report of two new patients. | Acta Myol | 2024 | 40017287 | PubTator, text mining | PubMed |
| Differential Expression Analyses on Human Aortic Tissue Reveal Novel Genes and Pathways Associated With Abdominal Aortic Aneurysm Onset and Progression. | J Am Heart Assoc | 2024 | 39655704 | PubTator, text mining | PubMed |
| Fhl1, a new spatially specific protein, regulates vein graft neointimal hyperplasia. | Clin Transl Med | 2024 | 39639552 | PubTator, text mining | PubMed |
| DNA Methylation Signatures Characterize Gene Expression Modulation in Lung Cancer Patients Affected by Anorexia. | Nutrients | 2024 | 39519555 | PubTator, text mining | PubMed |
| A prospective diagnostic model for breast cancer utilizing machine learning to examine the molecular immune infiltrate in HSPB6. | J Cancer Res Clin Oncol | 2024 | 39441229 | PubTator, text mining | PubMed |
| Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues. | Front Immunol | 2024 | 39281689 | PubTator, text mining | PubMed |
| SRSF2 is a key player in orchestrating the directional migration and differentiation of MyoD progenitors during skeletal muscle development. | Elife | 2024 | 39248331 | PubTator, text mining | PubMed |
| Enhancing prediction of short linear protein motifs with Wregex 3.0. | Comput Struct Biotechnol J | 2024 | 39135888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2273/papers?page=4